CASP9 and colorectal cancer: In MC38 colorectal cancer models, IR was ineffective in controlling caspase-9-proficient tumors, but effective in controlling caspase-9-deficient tumors, except when either cGAS or STING were knocked-out simultaneously with caspase 9 [22].